InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,182.62
(
-1.11%
)
Post# of 514
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kld2

Send PM Follow Ignore
Followers 20
Posts 1993
Boards Moderated 0
Alias Born 10/27/2013

kld2

Re: herbster post# 372

Friday, 02/17/2017 12:24:48 PM

Friday, February 17, 2017 12:24:48 PM

Post# of 514
Could be? Is. AA for breast cancer EOY. Plus bladder. Plus other indications. SGEN, more or less, is forking over 2b. VenBio said it was worth, if approved eoy, 1.5b. And that's only for breast cancer. Great data today on bladder. Roche recently got drug approved, but has way more adverse effects, including infertility.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up